{"id":"placebo-zonisamide","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Somnolence"}]},"_chembl":{"chemblId":"CHEMBL750","moleculeType":"Small molecule","molecularWeight":"212.23"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This action stabilizes neuronal membranes and suppresses the spread of seizure activity. Additionally, zonisamide may have a role in modulating glutamate release and inhibiting excitatory neurotransmission.","oneSentence":"Zonisamide is an anticonvulsant that works by blocking voltage-sensitive sodium channels in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:10.050Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Partial seizures"},{"name":"Generalized seizures"}]},"trialDetails":[{"nctId":"NCT04774250","phase":"PHASE2","title":"Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2021-11-10","conditions":"Hearing Loss, Noise-Induced","enrollment":3},{"nctId":"NCT05205811","phase":"PHASE3","title":"The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2021-12-14","conditions":"Smoking Cessation","enrollment":180},{"nctId":"NCT04768569","phase":"PHASE2","title":"Noise-Induced Hearing Loss-Acute Exposure Treatment","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2021-10-04","conditions":"Hearing Loss, Noise-Induced","enrollment":24},{"nctId":"NCT05134857","phase":"PHASE2","title":"The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study","status":"RECRUITING","sponsor":"Washington State University","startDate":"2022-01-07","conditions":"Alcohol Use Disorder (AUD)","enrollment":205},{"nctId":"NCT02901041","phase":"PHASE3","title":"Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism","status":"COMPLETED","sponsor":"Boston University Charles River Campus","startDate":"2017-09-21","conditions":"Alcohol Dependence","enrollment":81},{"nctId":"NCT04182399","phase":"NA","title":"Role of Zonisamide in Advanced Parkinson's Disease (PD) in Egyptian Population: Pilot Study","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-04-01","conditions":"Parkinson Disease","enrollment":69},{"nctId":"NCT02900352","phase":"PHASE3","title":"Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2016-10","conditions":"Alcohol Use Disorder","enrollment":156},{"nctId":"NCT01766128","phase":"PHASE2, PHASE3","title":"Study of Zonisamide in Early Parkinson Disease","status":"WITHDRAWN","sponsor":"Mazandaran University of Medical Sciences","startDate":"2013-02","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT03376139","phase":"PHASE2","title":"Zonisamide Outpatient Study","status":"WITHDRAWN","sponsor":"Pharmacotherapies for Alcohol and Substance Use Disorders Alliance","startDate":"2019-03-01","conditions":"Post Traumatic Stress Disorder, Alcohol Use Disorder","enrollment":""},{"nctId":"NCT02368431","phase":"PHASE3","title":"Effectiveness of Zonisamide in Alcohol Dependent Veterans","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2015-03-01","conditions":"Alcohol Use Disorder","enrollment":92},{"nctId":"NCT01847469","phase":"PHASE2","title":"Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-06","conditions":"Alcohol Dependence, Post-Traumatic Stress Disorder (PTSD)","enrollment":24},{"nctId":"NCT01713946","phase":"PHASE3","title":"A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-04-29","conditions":"Tuberous Sclerosis Complex-associated Refractory Seizures","enrollment":366},{"nctId":"NCT01685996","phase":"PHASE1, PHASE2","title":"Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-09","conditions":"Nicotine Dependence","enrollment":74},{"nctId":"NCT01137890","phase":"PHASE1, PHASE2","title":"Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2010-06","conditions":"Cocaine Dependence","enrollment":19},{"nctId":"NCT00398918","phase":"NA","title":"Alcohol Self Administration Laboratory","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-11","conditions":"Alcoholism","enrollment":10},{"nctId":"NCT00692003","phase":"PHASE3","title":"Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures","status":"TERMINATED","sponsor":"Eisai Limited","startDate":"2008-08-01","conditions":"Epilepsy","enrollment":21},{"nctId":"NCT01566370","phase":"PHASE2","title":"Zonisamide for Heavy Drinkers With Bipolar Disorder","status":"TERMINATED","sponsor":"Yale University","startDate":"2012-05","conditions":"Alcohol Use Disorders, Bipolar Disorder","enrollment":3},{"nctId":"NCT00275834","phase":"NA","title":"Zonisamide for Weight Reduction in Obese Adults","status":"COMPLETED","sponsor":"Duke University","startDate":"2006-01","conditions":"Obesity","enrollment":225},{"nctId":"NCT01136954","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)","status":"COMPLETED","sponsor":"Eisai Limited","startDate":"2008-07","conditions":"Partial Seizures","enrollment":144},{"nctId":"NCT01546688","phase":"PHASE4","title":"A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures","status":"TERMINATED","sponsor":"Eisai Limited","startDate":"2008-11","conditions":"Epilepsy","enrollment":41},{"nctId":"NCT00693017","phase":"PHASE3","title":"Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy","status":"TERMINATED","sponsor":"Eisai Limited","startDate":"2008-06","conditions":"Epilepsy","enrollment":10},{"nctId":"NCT00055484","phase":"PHASE2","title":"A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache","status":"COMPLETED","sponsor":"Elan Pharmaceuticals","startDate":"2002-03","conditions":"Migraine Headache","enrollment":204},{"nctId":"NCT00862563","phase":"PHASE2","title":"Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2009-05","conditions":"Alcoholism, Alcohol Dependence, Alcohol Abuse","enrollment":85},{"nctId":"NCT01806805","phase":"PHASE3","title":"Efficacy Trial of Zonisamide for Myoclonus Dystonia","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-02","conditions":"Myoclonus Dystonia","enrollment":24},{"nctId":"NCT00327717","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2006-09","conditions":"Partial Seizures","enrollment":240},{"nctId":"NCT01765608","phase":"PHASE2","title":"Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2010-03","conditions":"Sleep Apnea, Obstructive Sleep Apnea, Obesity","enrollment":50},{"nctId":"NCT00566254","phase":"PHASE3","title":"Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2008-12","conditions":"Epilepsy; Paediatric Partial Onset Seizures","enrollment":207},{"nctId":"NCT00709371","phase":"PHASE2","title":"Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity","status":"COMPLETED","sponsor":"Orexigen Therapeutics, Inc","startDate":"2008-07","conditions":"Obesity","enrollment":729},{"nctId":"NCT00734435","phase":"PHASE2","title":"Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects","status":"TERMINATED","sponsor":"Orexigen Therapeutics, Inc","startDate":"2008-09","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":26},{"nctId":"NCT00203450","phase":"PHASE4","title":"Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial","status":"COMPLETED","sponsor":"Tuscaloosa Research & Education Advancement Corporation","startDate":"2003-05","conditions":"Obesity","enrollment":20},{"nctId":"NCT00363376","phase":"PHASE3","title":"A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain","status":"COMPLETED","sponsor":"Lindner Center of HOPE","startDate":"2008-01","conditions":"Weight Gain","enrollment":42},{"nctId":"NCT00221442","phase":"PHASE3","title":"Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity","status":"COMPLETED","sponsor":"Lindner Center of HOPE","startDate":"2005-08","conditions":"Binge Eating Disorder Associated With Obesity","enrollment":60},{"nctId":"NCT00259636","phase":"PHASE4","title":"Zonisamide for Fibromyalgia & Migraine","status":"WITHDRAWN","sponsor":"University of Pittsburgh","startDate":"2004-08","conditions":"Fibromyalgia, Migraine","enrollment":""},{"nctId":"NCT00595556","phase":"PHASE4","title":"Zonisamide vs. Placebo in the Treatment of Alcohol Dependence","status":"COMPLETED","sponsor":"UConn Health","startDate":"2006-07","conditions":"Alcoholism, Alcohol Abuse, Alcohol Dependence","enrollment":40},{"nctId":"NCT00406692","phase":"PHASE2","title":"The Effects of Zonisamide on Alcohol Dependence","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-11","conditions":"Alcoholism","enrollment":16},{"nctId":"NCT00339014","phase":"PHASE2","title":"Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity","status":"COMPLETED","sponsor":"Orexigen Therapeutics, Inc","startDate":"2006-05","conditions":"Obesity","enrollment":611}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"TOXIC SKIN ERUPTION"}],"_approvalHistory":[],"publicationCount":147,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo zonisamide","genericName":"Placebo zonisamide","companyName":"Rose Research Center, LLC","companyId":"rose-research-center-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo zonisamide is a control intervention used in clinical trials for various conditions, including fibromyalgia, migraine, epilepsy, and post-traumatic stress disorder. Zonisamide, a small molecule sodium channel alpha subunit blocker, is a medication used to treat conditions such as epilepsy and has also been studied for other indications.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}